Filter News
Area of Research
- (-) Materials for Computing (3)
- (-) Nuclear Science and Technology (5)
- Advanced Manufacturing (2)
- Biology and Environment (39)
- Clean Energy (36)
- Climate and Environmental Systems (4)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (2)
- Fusion and Fission (10)
- Fusion Energy (8)
- Isotopes (9)
- Materials (24)
- Mathematics (1)
- National Security (14)
- Neutron Science (12)
- Quantum information Science (2)
- Supercomputing (24)
News Topics
- (-) Biomedical (4)
- (-) Environment (1)
- (-) Fusion (2)
- (-) Isotopes (4)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (6)
- Bioenergy (1)
- Chemical Sciences (3)
- Composites (1)
- Computer Science (4)
- Coronavirus (2)
- Decarbonization (1)
- Energy Storage (2)
- Materials (8)
- Materials Science (12)
- Microscopy (3)
- Molten Salt (3)
- Nanotechnology (4)
- National Security (1)
- Neutron Science (6)
- Nuclear Energy (17)
- Physics (1)
- Polymers (5)
- Quantum Science (2)
- Security (1)
- Space Exploration (5)
- Summit (1)
- Sustainable Energy (5)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
Scientists at Oak Ridge National Laboratory and the University of Tennessee designed and demonstrated a method to make carbon-based materials that can be used as electrodes compatible with a specific semiconductor circuitry.
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.